Longevity Venture Partners

www.longevityventurepartners.com

VCMatch tracks Longevity Venture Partners as an investor focused on Digital Health, Healthtech, and AI/ML companies, Seed and Series A rounds, and Israel, United States, and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Seed, Series A

Focus Areas

Digital Health, Healthtech, AI/ML

Geography

Israel, United States, and Global

Investment Thesis

Longevity Venture Partners is an early-stage VC focused on Silvertech, Healthcare and Wellness that seeks to improve the quality and longevity of the older and aging population by investing early and then accelerating commercial growth through a built-in clinical/commercial ecosystem. The firm treats technology as an enabler rather than a standalone answer and emphasizes validating products in real care settings before scaling — leveraging CommuniCare’s operational footprint, partners, and an international network of experts to test, pilot and commercialize solutions in the US.

Is Longevity Venture Partners right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Longevity Venture Partners is most relevant for founders raising Seed and Series A rounds in Digital Health, Healthtech, AI/ML, and Hardware, especially across Israel, United States, and Global.

Focus statement

They primarily invest at early stages in Silvertech, Healthcare and Wellness (and adjacent sectors aligned with their mission), targeting companies that can leverage their ecosystem as a launching pad into the US market; "The fund invests in four to six Israeli companies per year providing investment capital, industry expertise, access to our network of experts, and pilot ecosystem in the CommuniCare Family of Companies."

Value Add

Integrated commercial/pilot ecosystem via CommuniCare Family of Companies (96+ facilities, ~14,000 employees and multiple care products/services) that founders can use to test, validate and accelerate time-to-market.
Corporate investor partners (e.g., CommuniCare) who participate in due diligence, sit on the investment committee, and can become customers — aligning investor, operator and buyer interests.
Founder/operator expertise in large-scale post-acute and senior care (Stephen Rosedale, Ronald Wilheim) and clinical leadership on the team (e.g., Dr. Jonathan Ringo) enabling operational validation and go-to-market support in care settings.
Explicit go-to-market emphasis: prioritizes companies that can leverage their unique ecosystem to enter the US market, not just pure play tech investments.